Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|17|2933-2941

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.17, 2015-09, pp. : 2933-2941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract